Nektar Therapeutics (NKTR) PT Raised to $100 at BTIG, 'We see NKTR as a "pound the table BUY"'
Tweet Send to a Friend
BTIG analyst Julian Harrison raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $100.00 (from $60.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
